CohBar Presents Preclinical Data on CB4209/CB4211 Program for NASH at the AASLD Liver Meeting® 2017 Oct 23, 2017
CohBar, Inc. Announces Scientific Presentation of CB4209/CB4211 Program for NASH at The AASLD Liver Meeting® 2017 Oct 4, 2017
CohBar to Present at the Rodman & Renshaw 19th Annual Global Investment Conference in New York on September 12, 2017 Sep 8, 2017
CohBar, Inc. to Announce Second Quarter 2017 Financial Results and Host Conference Call for Shareholders on August 14, 2017 Jul 27, 2017
CohBar, Inc.’s CEO Simon Allen to Present at the 1st Annual H.C. Wainwright & Co. NASH Investor Conference in New York Mar 29, 2017
